Membrane Injury and Repair in the Muscular Dystrophies

Neuroscientist

Volumn 21, Issue 6, 2015, Pages 653-668

  Cooper, Sandra T ^a,b   Head, Stewart I ^c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

membrane repair; muscle damage; muscular dystrophy; skeletal muscle

Indexed keywords

DYSFERLIN; DYSTROPHIN; NITRIC OXIDE SYNTHASE; MEMBRANE PROTEIN; MUSCLE PROTEIN;

CELL REGENERATION; COSTAMERE; EXON; GENE MUTATION; HUMAN; LIPID BILAYER; MEMBRANE BIOLOGY; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MEMBRANE REPAIR; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE FIBER MEMBRANE; MUSCULAR DYSTROPHY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SKELETAL MUSCLE SATELLITE CELL; TRANSVERSE TUBULAR SYSTEM; ANIMAL; CELL MEMBRANE; INJURIES; METABOLISM; SKELETAL MUSCLE; SKELETAL MUSCLE CELL;

ANIMALS; CELL MEMBRANE; HUMANS; MEMBRANE PROTEINS; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES;

EID: 84946134064     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858414558336     Document Type: Review

References (109)

1. Achanzar WE, Ward S,. 1997. A nematode gene required for sperm vesicle fusion. J Cell Sci 110 (Pt 9): 1073-81.
2. Agre P, Orringer EP, Bennett V,. 1982. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med 306: 1155-61.
3. Allen DG,. 2001. Eccentric muscle damage: mechanisms of early reduction of force. Acta Physiol Scand 171: 311-9.
4. Allen DG, Gervasio OL, Yeung EW, Whitehead NP,. 2010. Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol 88: 83-91.
5. Allen DG, Whitehead NP,. 2011. Duchenne muscular dystrophy-what causes the increased membrane permeability in skeletal muscle? Int J Biochem Cell Biol 43: 290-4.
6. Ampong BN, Imamura M, Matsumiya T, Yoshida M, Takeda S,. 2005. Intracellular localization of dysferlin and its association with the dihydropyridine receptor. Acta Myol 24: 134-44.
7. Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, and others. 1999. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 8: 855-61.
8. Baltgalvis KA, Jaeger MA, Fitzsimons DP, Thayer SA, Lowe DA, Ervasti JM,. 2011. Transgenic overexpression of gamma-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice. Skelet Muscle 1: 32.
9. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, and others. 2003. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423: 168-72.
10. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, and others. 1998. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 20: 37-42.
11. Bell CD, Conen PE,. 1968. Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci 7: 529-44.
12. Berger J, Berger S, Hall TE, Lieschke GJ, Currie PD,. 2010. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscul Disord 20: 826-32.
13. Bloch RJ, Capetanaki Y, O'Neill A, Reed P, Williams MW, Resneck WG, and others. 2002. Costameres: repeating structures at the sarcolemma of skeletal muscle. Clin Orthop Relat Res (403): S203-10.
14. Bloch RJ, Gonzalez-Serratos H,. 2003. Lateral force transmission across costameres in skeletal muscle. Exerc Sport Sci Rev 31: 73-8.
15. Bodine DM, Birkenmeier CS, Barker JE,. 1984. Spectrin deficient inherited hemolytic anemias in the mouse: characterization by spectrin synthesis and mRNA activity in reticulocytes. Cell 37: 721-9.
16. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, and others. 1995. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 11: 266-73.
17. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, and others. 1996. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84: 757-67.
18. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, and others. 2001a. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 69: 1198-209.
19. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, and others. 2001b. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10: 2851-9.
20. Brose N, Petrenko AG, Sudhof TC, Jahn R,. 1992. Synaptotagmin: a calcium sensor on the synaptic vesicle surface. Science 256: 1021-5.
21. Bulfield G, Siller WG, Wight PA, Moore KJ,. 1984. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81: 1189-92.
22. Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, and others. 2009. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 11: 56-64.
23. Campbell KP, Kahl SD,. 1989. Association of dystrophin and an integral membrane glycoprotein. Nature 338: 259-62.
24. Chan S, Head SI, Morley JW,. 2007. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. Am J Physiol Cell Physiol 293: C985-92.
25. Chao DS, Gorospe JR, Brenman JE, Rafael JA, Peters MF, Froehner SC, and others. 1996. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 184: 609-18.
26. Chelly J, Desguerre I,. 2013. Progressive muscular dystrophies. Handb Clin Neurol 113: 1343-66.
27. Claflin DR, Brooks SV,. 2008. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy. Am J Physiol Cell Physiol 294: C651-8.
28. Covian-Nares JF, Koushik SV, Puhl HL 3rd, Vogel SS,. 2010. Membrane wounding triggers ATP release and dysferlin-mediated intercellular calcium signaling. J Cell Sci 123: 1884-93.
29. Crosbie RH,. 2001. NO vascular control in Duchenne muscular dystrophy. Nat Med 7: 27-9.
30. Crosbie RH, Barresi R, Campbell KP,. 2002. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J 16: 1786-91.
31. Dangain J, Vrbova G,. 1984. Muscle development in mdx mutant mice. Muscle Nerve 7: 700-4.
32. Dulhunty AF, Franzini-Armstrong C,. 1975. The relative contributions of the folds and caveolae to the surface membrane of frog skeletal muscle fibres at different sarcomere lengths. J Physiol 250: 513-39.
33. Edwards JN, Launikonis BS,. 2008. The accessibility and interconnectivity of the tubular system network in toad skeletal muscle. J Physiol 586: 5077-89.
34. Elferink LA, Peterson MR, Scheller RH,. 1993. A role for synaptotagmin (p65) in regulated exocytosis. Cell 72: 153-9.
35. Emery AE,. 2002. The muscular dystrophies. Lancet 359: 687-95.
36. Endo M, Tanaka M, Ogawa Y,. 1970. Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibres. Nature 228: 34-6.
37. Ervasti JM,. 2003. Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 278: 13591-4.
38. Ervasti JM,. 2007. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 1772: 108-17.
39. Ervasti JM, Campbell KP,. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-23.
40. Essen LO, Perisic O, Cheung R, Katan M, Williams RL,. 1996. Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta. Nature 380: 595-602.
41. Friden J, Sjostrom M, Ekblom B,. 1983. Myofibrillar damage following intense eccentric exercise in man. Int J Sports Med 4: 170-6.
42. Fuson K, Rice A, Mahling R, Snow A, Nayak K, Shanbhogue P, and others. 2014. Alternate splicing of dysferlin C2A confers Ca(2)(+)-dependent and Ca(2)(+)-independent binding for membrane repair. Structure 22: 104-15.
43. Grange RW, Gainer TG, Marschner KM, Talmadge RJ, Stull JT,. 2002. Fast-twitch skeletal muscles of dystrophic mouse pups are resistant to injury from acute mechanical stress. Am J Physiol Cell Physiol 283: C1090-101.
44. Hamill OP, Martinac B,. 2001. Molecular basis of mechanotransduction in living cells. Physiol Rev 81: 685-740.
45. Head SI,. 2010. Branched fibres in old dystrophic mdx muscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a breakdown of Ca2+ homeostasis during fatigue. Exp Physiol 95: 641-56.
46. Head SI, Williams DA, Stephenson DG,. 1992. Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice. Proc Biol Sci 248: 163-9.
47. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, and others. 1995. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 11: 216-8.
48. Hoffman EP, Brown RH Jr, Kunkel LM,. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-28.
49. Jones DA, Newham DJ, Clarkson PM,. 1987. Skeletal muscle stiffness and pain following eccentric exercise of the elbow flexors. Pain 30: 233-42.
50. Jones DA, Newham DJ, Round JM, Tolfree SE,. 1986. Experimental human muscle damage: morphological changes in relation to other indices of damage. J Physiol 375: 435-48.
51. Kerr JP, Ziman AP, Mueller AL, Muriel JM, Kleinhans-Welte E, Gumerson JD, and others. 2013. Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane. Proc Natl Acad Sci U S A 110: 20831-6.
52. Klinge L, Aboumousa A, Eagle M, Hudson J, Sarkozy A, Vita G, and others. 2010. New aspects on patients affected by dysferlin deficient muscular dystrophy. J Neurol Neurosurg Psychiatry 81: 946-53.
53. Klinge L, Laval S, Keers S, Haldane F, Straub V, Barresi R, and others. 2007. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis. FASEB J 21: 1768-76.
54. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, and others. 1998. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394: 388-92.
55. Krahn M, Labelle V, Borges A, Bartoli M, Levy N,. 2010a. Exclusion of mutations in the dysferlin alternative exons 1 of DYSF-v1, 5a, and 40a in a cohort of 26 patients. Genet Test Mol Biomarkers 14: 153-4.
56. Krahn M, Wein N, Bartoli M, Lostal W, Courrier S, Bourg-Alibert N, and others. 2010b. A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy. Sci Transl Med 2: 50ra69.
57. Kuru S, Yasuma F, Wakayama T, Kimura S, Konagaya M, Aoki M, and others. 2004. A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy. Rinsho Shinkeigaku 44: 375-8.
58. Lai Y, Thomas GD, Yue Y, Yang HT, Li D, Long C, and others. 2009. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 119: 624-35.
59. Lamb GD,. 2005. Rippling muscle disease may be caused by €silent€ action potentials in the tubular system of skeletal muscle fibers. Muscle Nerve 31: 652-8.
60. Le Rumeur E, Winder SJ, Hubert JF,. 2010. Dystrophin: more than just the sum of its parts. Biochim Biophys Acta 1804: 1713-22.
61. Lek A, Evesson FJ, Lemckert FA, Redpath GM, Lueders AK, Turnbull L, and others. 2013. Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repair. J Neurosci 33: 5085-94.
62. Lek A, Lek M, North KN, Cooper ST,. 2010. Phylogenetic analysis of ferlin genes reveals ancient eukaryotic origins. BMC Evol Biol 10: 231.
63. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, and others. 1995. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 11: 257-65.
64. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, and others. 1998. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20: 31-6.
65. Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V, and others. 2008. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord 18: 34-44.
66. Lostal W, Bartoli M, Bourg N, Roudaut C, Bentaib A, Miyake K, and others. 2010. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer. Hum Mol Genet 19: 1897-907.
67. Loufrani L, Matrougui K, Gorny D, Duriez M, Blanc I, Levy BI, and others. 2001. Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation 103: 864-70.
68. McArdle A, Edwards RH, Jackson MJ,. 1991. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse. Clin Sci 80: 367-71.
69. McNeil P,. 2009. Membrane repair redux: redox of MG53. Nat Cell Biol 11: 7-9.
70. McNeil PL, Baker MM,. 2001. Cell surface events during resealing visualized by scanning-electron microscopy. Cell Tissue Res 304: 141-6.
71. McNeil PL, Khakee R,. 1992. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 140: 1097-109.
72. Mercuri E, Muntoni F,. 2013. Muscular dystrophies. Lancet 381: 845-60.
73. Moens P, Baatsen PH, Marechal G,. 1993. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14: 446-451.
74. Mokri B, Engel AG,. 1975. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25: 1111-20.
75. Nalefski EA, Falke JJ,. 1998. Location of the membrane-docking face on the Ca2+-activated C2 domain of cytosolic phospholipase A2. Biochemistry 37: 17642-50.
76. Newham DJ, Jones DA, Edwards RH,. 1986. Plasma creatine kinase changes after eccentric and concentric contractions. Muscle Nerve 9: 59-63.
77. Nguyen K, Bassez G, Krahn M, Bernard R, Laforet P, Labelle V, and others. 2007. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 64: 1176-82.
78. Nigro V, de Sa Moreira E, Piluso G, Vainzof M, Belsito A, Politano L, and others. 1996. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 14: 195-8.
79. Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, and others. 1995. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 270: 819-22.
80. Ohsako T, Hirai K, Yamamoto MT,. 2003. The Drosophila misfire gene has an essential role in sperm activation during fertilization. Genes Genet Syst 78: 253-66.
81. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL,. 1993. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90: 3710-4.
82. Piccolo F, Moore SA, Ford GC, Campbell KP,. 2000. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann Neurol 48: 902-12.
83. Pichavant C, Pavlath GK,. 2014. Incidence and severity of myofiber branching with regeneration and aging. Skelet Muscle 4: 9.
84. Pramono ZA, Tan CL, Seah IA, See JS, Kam SY, Lai PS, and others. 2009. Identification and characterisation of human dysferlin transcript variants: implications for dysferlin mutational screening and isoforms. Hum Genet 125: 413-20.
85. Proske U, Morgan DL,. 2001. Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 537: 333-45.
86. Redpath G, Woolger N, Piper A, Lemckert F, Lek A, Greer P, and others. 2014. Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair. Mol Biol Cell 25: 3037-48.
87. Relaix F, Zammit PS,. 2012. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139: 2845-56.
88. Roberds SL, Leturcq F, Allamand V, Piccolo F, Jeanpierre M, Anderson RD, and others. 1994. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 78: 625-33.
89. Roux I, Safieddine S, Nouvian R, Grati M, Simmler MC, Bahloul A, and others. 2006. Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 127: 277-89.
90. Schmalbruch H,. 1984. Regenerated muscle fibers in Duchenne muscular dystrophy: a serial section study. Neurology 34: 60-5.
91. Schwane JA, Johnson SR, Vandenakker CB, Armstrong RB,. 1983. Delayed-onset muscular soreness and plasma CPK and LDH activities after downhill running. Med Sci Sports Exerc 15: 51-6.
92. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, and others. 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-5.
93. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, and others. 2000. Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 275: 38048-58.
94. Steinhardt RA, Bi G, Alderton JM,. 1994. Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science 263: 390-3.
95. Sutton RB, Davletov BA, Berghuis AM, Sudhof TC, Sprang SR,. 1995. Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell 80: 929-38.
96. Terasaki M, Miyake K, McNeil PL,. 1997. Large plasma membrane disruptions are rapidly resealed by Ca2+-dependent vesicle-vesicle fusion events. J Cell Biol 139: 63-74.
97. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, Victor RG,. 1998. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 95: 15090-5.
98. Waddell LB, Lemckert FA, Zheng XF, Tran J, Evesson FJ, Hawkes JM, and others. 2011. Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch. J Neuropathol Exp Neurol 70: 302-13.
99. Warren GL, Ingalls CP, Lowe DA, Armstrong RB,. 2001. Excitation-contraction uncoupling: major role in contraction-induced muscle injury. Exerc Sport Sci Rev 29: 82-7.
100. Wehling M, Spencer MJ, Tidball JG,. 2001. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155: 123-31.
101. Weisleder N, Takizawa N, Lin P, Wang X, Cao C, Zhang Y, and others. 2012. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med 4: 139ra185.
102. Wenzel K, Geier C, Qadri F, Hubner N, Schulz H, Erdmann B, and others. 2007. Dysfunction of dysferlin-deficient hearts. J Mol Med (Berl) 85: 1203-14.
103. Whitehead NP, Streamer M, Lusambili LI, Sachs F, Allen DG,. 2006. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice. Neuromuscul Disord 16: 845-54.
104. Yasunaga S, Grati M, Cohen-Salmon M, El-Amraoui A, Mustapha M, Salem N, and others. 1999. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 21: 363-9.
105. Yeung EW, Balnave CD, Ballard HJ, Bourreau JP, Allen DG,. 2002. Development of T-tubular vacuoles in eccentrically damaged mouse muscle fibres. J Physiol 540: 581-92.
106. Yeung EW, Whitehead NP, Suchyna TM, Gottlieb PA, Sachs F, Allen DG,. 2005. Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse. J Physiol 562: 367-80.
107. Yin H, Price F, Rudnicki MA,. 2013. Satellite cells and the muscle stem cell niche. Physiol Rev 93: 23-67.
108. Zhang Y, Yue Y, Li L, Hakim CH, Zhang K, Thomas GD, and others. 2013. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Hum Mol Genet 22: 3720-9.
109. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, and others. 1988. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333: 466-9.